Cover Image
QR Code

Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical Data.

Published in:Advances in Therapy Vol. 42; no. 11; pp. 5781 - 5794
Main Authors: Santos, Sandra, Robinson, Tara M., Trueman, David
Format: Journal Article
Published: Springer Nature Nov2025
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=189054294&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 189054294
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0741238X
        1XDX
      jtl: Advances in Therapy
      issn: 0741238X
      maglogo: N
    pubinfo:
      dt: Nov2025
      vid: 42
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        189054294
        188145236
        10.1007/s12325-025-03368-4
        189054294
      ppf: 5781
      ppct: 13
      formats:
      tig:
        atl: Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical Data.
      aug:
        au:
          Santos, Sandra
          Robinson, Tara M.
          Trueman, David
        affil: https://ror.org/0103q2z38 BioMarin UK Ltd., 10 Bloomsbury Way, WC1A 2SL, London, UK
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N